HRP20080070T3 - Pyrrazolo-pyrimidine derivatives - Google Patents

Pyrrazolo-pyrimidine derivatives

Info

Publication number
HRP20080070T3
HRP20080070T3 HR20080070T HRP20080070T HRP20080070T3 HR P20080070 T3 HRP20080070 T3 HR P20080070T3 HR 20080070 T HR20080070 T HR 20080070T HR P20080070 T HRP20080070 T HR P20080070T HR P20080070 T3 HRP20080070 T3 HR P20080070T3
Authority
HR
Croatia
Prior art keywords
lower alkyl
carbon atoms
ring
straight
optionally substituted
Prior art date
Application number
HR20080070T
Other languages
English (en)
Croatian (hr)
Inventor
Goetschi Erwin
Wichmann Juergen
Johannes Woltering Thomas
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20080070T3 publication Critical patent/HRP20080070T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20080070T 2004-06-21 2005-06-13 Pyrrazolo-pyrimidine derivatives HRP20080070T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04102837 2004-06-21
PCT/EP2005/006302 WO2005123738A1 (fr) 2004-06-21 2005-06-13 Derives de pyrrazolo-pyrimidine

Publications (1)

Publication Number Publication Date
HRP20080070T3 true HRP20080070T3 (en) 2008-05-31

Family

ID=34971089

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080070T HRP20080070T3 (en) 2004-06-21 2005-06-13 Pyrrazolo-pyrimidine derivatives

Country Status (25)

Country Link
US (1) US7378417B2 (fr)
EP (1) EP1761541B1 (fr)
JP (1) JP4608542B2 (fr)
CN (1) CN100528876C (fr)
AR (1) AR049521A1 (fr)
AT (1) ATE383361T1 (fr)
AU (1) AU2005254657B2 (fr)
BR (1) BRPI0512330A (fr)
CA (1) CA2571487C (fr)
DE (1) DE602005004287T2 (fr)
DK (1) DK1761541T3 (fr)
ES (1) ES2299044T3 (fr)
HR (1) HRP20080070T3 (fr)
IL (1) IL179736A (fr)
MX (1) MXPA06014809A (fr)
MY (1) MY143368A (fr)
NO (1) NO20070249L (fr)
NZ (1) NZ551660A (fr)
PL (1) PL1761541T3 (fr)
PT (1) PT1761541E (fr)
RU (1) RU2378277C2 (fr)
SI (1) SI1761541T1 (fr)
TW (1) TWI301835B (fr)
WO (1) WO2005123738A1 (fr)
ZA (1) ZA200610102B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101115755B (zh) * 2005-02-11 2013-01-16 弗·哈夫曼-拉罗切有限公司 作为mglur2拮抗剂的吡唑并-嘧啶衍生物
DE602006012815D1 (de) 2005-03-23 2010-04-22 Hoffmann La Roche Acetylenylpyrazolopyrimidinderivate als mglur2-antagonsten
AU2006298829B2 (en) 2005-09-27 2011-03-03 F. Hoffmann-La Roche Ag Oxadiazolyl pyrazolo-pyrimidines as mGluR2 antagonists
CA2626789A1 (fr) * 2005-10-21 2007-04-26 Exelixis, Inc. Pyrimidinones en tant que modulateurs de caseine kinase ii (ck2)
AU2008279759A1 (en) * 2007-07-20 2009-01-29 Merck & Co., Inc. Pyrazolo[1,5-a]pyrimidine derivatives
CN102271515B (zh) * 2008-10-31 2014-07-02 健泰科生物技术公司 吡唑并嘧啶jak抑制剂化合物和方法
AR078171A1 (es) * 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
WO2012075393A2 (fr) * 2010-12-02 2012-06-07 President And Fellows Of Harvard College Activateurs de la dégradation protéasomique et leurs utilisations
DK2649075T3 (en) * 2010-12-08 2018-07-30 Us Health SUBSTITUTED PYRAZOLOPYRIMIDINES AS GLUCOCEREBROSIDASE ACTIVATORS
WO2012149157A2 (fr) 2011-04-26 2012-11-01 Bioenergenix Composés hétérocycliques pour l'inhibition de pask
WO2013148333A1 (fr) 2012-03-28 2013-10-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Dérivés d'acide salicylique utiles à titre d'activateurs de glucocérébrosidase
EP2925292A1 (fr) 2012-10-23 2015-10-07 F. Hoffmann-La Roche AG Antagonistes de mglu2/3 pour le traitement de troubles autistiques
WO2014066795A1 (fr) 2012-10-25 2014-05-01 Bioenergenix Composés hétérocycliques pour l'inhibition de pask
WO2014066743A1 (fr) 2012-10-25 2014-05-01 Bioenergenix Composés hétérocycliques pour l'inhibition de pask
KR20160143853A (ko) 2014-04-23 2016-12-14 에프. 호프만-라 로슈 아게 지적 장애의 치료를 위한 mglu2/3 길항제
JOP20150179B1 (ar) * 2014-08-01 2021-08-17 Janssen Pharmaceutica Nv مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2
EP3000814A1 (fr) 2014-09-26 2016-03-30 Domain Therapeutics Pyrazoloquinazolinones et pyrroloquinazolinones substitués en tant que modulateurs allostériques des récepteurs métabotropiques du glutamate du groupe II
WO2016073889A1 (fr) 2014-11-06 2016-05-12 Lysosomal Therapeutics Inc. Imidazo[1,5-a]pyrimidines substituées et leur utilisation dans le traitement de troubles médicaux
AU2015342883B2 (en) 2014-11-06 2020-07-02 Bial - R&D Investments, S.A. Substituted pyrrolo(1,2-a)pyrimidines and their use in the treatment of medical disorders
HRP20240644T1 (hr) 2014-11-06 2024-08-02 Bial-R&D Investments, S.A. Supstituirani pirazolo(1,5-a)pirimidini i njihova uporaba u liječenju medicinskih poremećaja
JP6861154B2 (ja) 2014-12-03 2021-04-21 ヤンセン ファーマシューティカ エヌ．ベー． 放射標識されたｍＧｌｕＲ２ ＰＥＴリガンド
US10738016B2 (en) 2015-10-13 2020-08-11 H. Lee Moffitt Cancer Center And Research Institute, Inc. BRD4-kinase inhibitors as cancer therapeutics
EA037941B1 (ru) 2015-12-18 2021-06-09 Янссен Фармацевтика Нв ЛИГАНДЫ mGluR2/3 ДЛЯ PET, МЕЧЕННЫЕ РАДИОАКТИВНЫМИ ИЗОТОПАМИ
LT3389727T (lt) 2015-12-18 2020-10-12 Janssen Pharmaceutica Nv Radioaktyviai pažymėti mglur2/3 pet ligandai
EP3440081A4 (fr) 2016-04-06 2019-09-18 Lysosomal Therapeutics Inc. Composés pyrrolo[1,2-a]pyrimidinyl carboxamide et leur utilisation dans le traitement de troubles médicaux
US11192892B2 (en) * 2016-04-06 2021-12-07 Bial—R&D Investments, S.A. Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders
CA3020305A1 (fr) 2016-04-06 2017-10-12 Lysosomal Therapeutics Inc. Composes imidazo [1,5-a]pyrimidinyl carboxamide et leur utilisation dans le traitement de troubles medicaux
EP3452455A4 (fr) 2016-05-05 2019-11-13 Lysosomal Therapeutics Inc. Imidazo[1,2-a]pyridines substituées, imidazo[1,2-a]pyrazines substituées, composés apparentés et leur utilisation dans le traitement de troubles médicaux
SG11201809693SA (en) 2016-05-05 2018-11-29 Lysosomal Therapeutics Inc SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
JP7619951B2 (ja) * 2018-10-15 2025-01-22 武田薬品工業株式会社 Ｔｙｋ２阻害剤およびその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017212A (en) * 1986-03-20 1991-05-21 Takeda Chemical Industries, Ltd. Sulfonylurea compounds and herbicidal use
EP0729758A3 (fr) * 1995-03-02 1997-10-29 Pfizer Pyrazolopyrimidines et pyrrolopyrimidines pour traiter les troubles neuronaux et autres maladies
GB9712718D0 (en) * 1997-06-18 1997-08-20 Heights Design Production Ltd Binding apparatus
EP0891978B1 (fr) * 1997-07-18 2002-03-20 F. Hoffmann-La Roche Ag Dérivés de 5H-thiazolo[3,2-a]pyrimidine
JP2003510325A (ja) * 1999-09-30 2003-03-18 ニューロジェン・コーポレーション ある種のアルキレンジアミン−置換ピラゾロ［１，５−ａ］−１，５−ピリミジン及びピラゾロ［１，５−ａ］−１，３，５−トリアジン
SK13682003A3 (sk) * 2001-04-12 2004-07-07 F. Hoffmann-La Roche Ag Dihydrobenzo[b][1,4]diazepin-2-ónové deriváty ako mGluR2 antagonisty II
EP1490364B1 (fr) * 2002-03-28 2007-09-26 Eisai R&D Management Co., Ltd. 7-azaindoles en tant qu'inhibiteurs de kinases a terminaison c-jun n pour le traitement de troubles neurodegeneratifs
US7329662B2 (en) * 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine

Also Published As

Publication number Publication date
AU2005254657A1 (en) 2005-12-29
CA2571487A1 (fr) 2005-12-29
JP2008503510A (ja) 2008-02-07
WO2005123738A1 (fr) 2005-12-29
MXPA06014809A (es) 2007-02-12
RU2378277C2 (ru) 2010-01-10
PL1761541T3 (pl) 2008-06-30
CN1964973A (zh) 2007-05-16
NO20070249L (no) 2007-02-15
TWI301835B (en) 2008-10-11
DE602005004287T2 (de) 2008-12-24
JP4608542B2 (ja) 2011-01-12
ATE383361T1 (de) 2008-01-15
AR049521A1 (es) 2006-08-09
ZA200610102B (en) 2008-08-27
PT1761541E (pt) 2008-03-13
HK1105971A1 (zh) 2008-02-29
NZ551660A (en) 2009-08-28
MY143368A (en) 2011-04-29
US20050282827A1 (en) 2005-12-22
IL179736A (en) 2010-12-30
RU2006143571A (ru) 2008-07-27
US7378417B2 (en) 2008-05-27
EP1761541B1 (fr) 2008-01-09
TW200626598A (en) 2006-08-01
DK1761541T3 (da) 2008-04-28
DE602005004287D1 (de) 2008-02-21
IL179736A0 (en) 2007-05-15
AU2005254657B2 (en) 2011-03-17
BRPI0512330A (pt) 2008-02-26
CN100528876C (zh) 2009-08-19
CA2571487C (fr) 2013-04-30
ES2299044T3 (es) 2008-05-16
SI1761541T1 (sl) 2008-06-30
EP1761541A1 (fr) 2007-03-14

Similar Documents

Publication Publication Date Title
HRP20080070T3 (en) Pyrrazolo-pyrimidine derivatives
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
UY27336A1 (es) Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6
AR078833A1 (es) Derivados de heteroarilos que contienen nitrogeno como inhibidores dela cinasa jak3
AR063022A1 (es) Derivados de indol antagonistas del receptor de glucagon, composiciones farmaceuticas que los contienen y usos para tratar diabetes mellitus tipo 2 y estados patologicos relacionados.
PE20040832A1 (es) Derivados de indolil pirazinona
ME00555A (en) Tryasolyl tropane derivatives as ccr5 modulators
HRP20110498T1 (hr) Azetidini kao inhibitori mek za liječenje proliferativnih bolesti
PA8575401A1 (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso
AR049291A1 (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
EA200100902A1 (ru) Производные тетрагидропирана и их использование в качестве терапевтических агентов
SE0201937D0 (sv) Therapeutic agents
AR047369A1 (es) N-cicloalquil, aril o heteroaril-n??-quinolin-2-ilcicloalquildiaminas, procesos para preparar tales compuestos y composiciones farmaceuticas que las contienen
AR035254A1 (es) Derivados fluorquinolonicos de oxazolidinonas utiles como antibacterianos, procedimiento para su obtencion y su utilizacion para la preparacion de una composicion farmaceutica
EA201690408A1 (ru) Производные этинила
AR064198A1 (es) Piperidinilamino piridazinas como antagonistas del receptor de dopamina 2 de rapida disociacion. procesos de obtencion y composiciones farmaceuticas
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
AR071278A1 (es) Derivados de alfa -aminoamida utiles en el tratamiento de los trastornos psiquiatricos, y formulaciones farmaceuticas que los contienen
HRP20090127T3 (en) Carboxamide derivatives as muscarinic receptor antagonists
PE20030719A1 (es) Derivados de 8-[bis(2-halofenil)metil]-3-heteroaril-8-azabiciclo[3.2.1] octan-3-ol como agonistas del receptor de nociceptina orl-1
AR044470A1 (es) Derivados de pirrol sustituidos
AR038005A1 (es) Antibacterianos 6-o-acil cetolidos
PE20210403A1 (es) Derivados de 10-(di(fenil)metil)-4-hidroxi-8,9,9a,10-tetrahidro-7h-pirrolo [1',2':4,5]pirazino[1,2-b]piridazina-3,5-diona y compuestos relacionados como inhibidores de la replicacion del ortomixovirus para el tratamiento de la influenza
AR043835A1 (es) Pirazoles sustituidos, un procedimiento para su preparacion, el uso de los mismos para preparar un medicamento, las preparaciones farmaceuticas que los contienen y un procedimiento para obtener dichas preparaciones farmaceuticas
AR045376A1 (es) Uso de alcoxilatos de alcohol como adyuvantes para derivados de benzamidoxima fungicidas, agentes y kits correspondientes